FRIULCHEM S.P.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.905 EUR | -2.69% |
|
-3.72% | -9.50% |
| Mar. 22 | Friulchem returns to profit in 2023; increases financial debt | AN |
| Mar. 22 | Friulchem S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2023 | 26.66M 28.71M | Sales 2024 * | 30.5M 32.85M | Capitalization | 5.43M 5.85M |
|---|---|---|---|---|---|
| Net income 2023 | - 0 | Net income 2024 * | - 0 | EV / Sales 2023 | 0.55 x |
| Net Debt 2023 | 8.62M 9.28M | Net Debt 2024 * | 12.7M 13.68M | EV / Sales 2024 * | 0.59 x |
| P/E ratio 2023 * |
-22.6
x | P/E ratio 2024 * |
-90.5
x | Employees | 86 |
| Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 41.47% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -2.69% | ||
| 1 week | -3.72% | ||
| Current month | -8.12% | ||
| 1 month | -8.12% | ||
| 3 months | -9.50% | ||
| 6 months | -11.27% | ||
| Current year | -9.50% |
1 week
0.91
0.94
1 month
0.891.04
Current year
0.891.05
1 year
0.891.21
3 years
0.891.41
5 years
0.891.97
10 years
0.891.97
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | - | |
Carlo Marelli
DFI | Director of Finance/CFO | 51 | 08-12-31 |
Silvia Moiana
COO | Chief Operating Officer | 48 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 85 | 19-06-27 | |
Roberta Terpin
BRD | Director/Board Member | 46 | - |
| Chief Executive Officer | 50 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-10 | 0.905 | -2.69% | 750 |
| 24-05-09 | 0.93 | 0.00% | 0 |
| 24-05-08 | 0.93 | 0.00% | 0 |
| 24-05-07 | 0.93 | +1.09% | 750 |
| 24-05-06 | 0.92 | -2.13% | 12,000 |
Real-time Borsa Italiana, May 10, 2024 at 11:44 am EDT
More quotes
Friulchem SpA is an Italy-based private chemical-pharmaceutical company dealing with research, development and production of pharmaceutical products for both human and veterinary fields.
Sector
Pharmaceuticals
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.905
EUR
Average target price
1.2
EUR
Spread / Average Target
+32.60%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -9.50% | 5.85M | |
| +30.38% | 684B | |
| +26.51% | 568B | |
| -4.36% | 361B | |
| +19.30% | 329B | |
| +3.73% | 284B | |
| +16.70% | 240B | |
| +8.78% | 208B | |
| -7.93% | 200B | |
| +7.68% | 166B |
- Stock Market
- Equities
- FCM Stock
